BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 5, 2003
View Archived Issues
Systemic inflammation increases cardiovascular risk in rheumatoid arthritis
Read More
Relationship between fracture risk reduction and improvement in BMD
Read More
Study of transplanted replacement islets without long-term immune suppression
Read More
metaGen to merge with Astex Technology
Read More
Cell patch cardiomyoplasty potentially useful in the surgical treatment of heart failure
Read More
Efficacy of omalizumab in concomitant asthma and rhinitis
Read More
Potential therapeutic role suggested for simvastatin in pulmonary hypertension
Read More
New 5-HT6 receptor ligands and their use reported by GSK researchers
Read More
Novel cytokine release inhibitors identified at Procter & Gamble
Read More
Merck presents new KSP inhibitors with utility in cancer therapy
Read More
Shionogi team synthesizes new antibacterial cephems
Read More
Merz claims new antagonists of NMDA, 5-HT3 and acetylcholine receptors and their use
Read More
New analgesic vanilloid VR1 antagonists identified at Merck
Read More
Two series of PAI-1 inhibitors designed by Schering AG researchers
Read More
Improved quality of life associated with cilomilast in COPD
Read More
Benefits described for pirfenidone in the treatment of NASH and liver cirrhosis
Read More
Preclinical and clinical development efforts at Actelion
Read More
Avigen presents phase I protocol for AV-201 to FDA advisory committee
Read More
Approval received for Sucanon in Mexico
Read More
Chiron grants license to Rigel for hepatitis C technology
Read More
IR-103 enters preclinical development program for HIV
Read More
Enrollment completed in phase IV pediatric study of Altace
Read More
Merck subsidiary seeks approval for Erbitux in Australia
Read More
Positive results reported from phase IIb study of PT-141
Read More
NDA submitted for pregabalin
Read More
Uroxatral launched in U.S.
Read More
Teva announces plans to acquire Sicor
Read More
DTI grant for Xcellsyz drug development efforts
Read More
